Molecular Imaging and Therapy of Neuroendocrine Tumors

Main Article Content

Saima Muzahir, MD
Erin E. Grady, MD


Neuroendocrine tumors are a diverse group of neoplastic entities with variable degrees of neuroendocrine differentiation that are imaged and, in some cases, treated with nuclear medicine techniques. They are generally uncommon, with an incidence of 50 per million people, and are often considered ‘zebra’ diagnoses. This chapter provides an overview of molecular imaging and therapy of neuroendocrine tumors with radiopharmaceuticals including 111In-octreotide, 123I-mIBG, 131I-mIBG, 68Ga- or 64Cu-DOTATATE, 177Lu DOTATATE, and 18F-FDG. The biodistribution of these radiopharmaceuticals is reviewed along with dosing and, for therapies, the inclusion and exclusion criteria.


Download data is not yet available.


Metrics Loading ...

Article Details

Chapter 8